Clinical Trials Sponsored by Medisim Ltd

Total 17896 results

Medisim Ltd

Unknown

Clinical Evaluation of the Care On Line Thermometer

Healthy

Israel
Medisim Ltd

Unknown

Temple Touch Pro (TTP) Non Invasive Continuous Temperature Measurement System (TTP)

Body Temperature During Surgery

Israel
Medisim Ltd

Unknown

Temple Touch Pro (TTP) Non-Invasive Core Temperature Monitoring as a Measure for Early Detection of Fever Related Infections, Including Sepsis. (TTP)

Patients in ICU

Israel
Medisim Ltd

Unknown

Temperature Measurement Using a Non Invasive Device

Body Temperature Measurement

Israel
Medisim Ltd

Completed

Clinical Evaluation of NIR (Non-Invasive Infrared) Thermometer Performance (NIR)

Elevated Temperature

Israel
Medistim ASA

Not yet recruiting

Collect Flow and Ultrasound Images of Coronary Bypass Grafts (CASES)

Cardiac Bypass Surgery (CABG)
Medistim ASA

Not yet recruiting

Peripheral Bypass Trial for Completion Control (PATENT)

Chronic Limb-Threatening Ischemia
Medistim ASA

Completed

Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery (REQUEST)

Coronary Artery Bypass

United States, United Kingdom, Netherlands, Canada, Germany, Italy
Medivir

Completed

A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients

Osteoarthritis, Knee

Bulgaria, Georgia, Germany, Moldova, Republic of
Medivir

Completed

Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents

Herpes Labialis
Medivir

Completed

Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis

Herpes Labialis
Medivir

Active, not recruiting

A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations

Hepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver Metastases

Korea, Republic of, Spain, Belgium, United Kingdom
Medivir

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients

Osteoarthritis, Knee

Bulgaria, Georgia, Germany, Moldova, Republic of, Romania, United Kingdom
Medivir

Completed

A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers

Healthy

United States
Medivir

Completed

Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis

Herpes Labialis

United States
Medivir

Completed

Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients

Herpes Labialis
MedSIR

Not yet recruiting

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression (ANALLISA)

Ovarian Cancer | Oligometastatic Disease | Serous Ovarian Tumor
MedSIR

Not yet recruiting

A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population (MiRaDoR)

Breast Cancer
MedSIR

Active, not recruiting

Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. (PHERGain)

Breast Cancer

Spain, Italy, France, United Kingdom, Germany, Portugal, Belgium
MedSIR

Withdrawn

POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer (POLTER)

Advanced Breast Cancer
MedSIR

Terminated

Checkpoint Blockade in COVID-19 Pandemic (COPERNICO)

COVID-19 | Pneumonia, Viral

Spain
MedSIR

Recruiting

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% (EMPRESS)

Breast Cancer | Breast Cancer, Early-Onset

Spain, France
MedSIR

Active, not recruiting

Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients (Phenomenal)

Breast Cancer Metastatic

Spain
MedSIR

Completed

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer (PARSIFAL)

Metastatic Breast Cancer

Spain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
MedSIR

Completed

Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib (TRASTYVERE)

Breast Neoplasm

Spain
Medibio Limited

Recruiting

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) (SAMDE)

Depressive Disorder | Depression | Depressive Disorder, Major | Depressive Episode | Depression Mild

United States
Alyatec
Medicom

Completed

Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber

Allergic Rhinitis | Allergic Asthma

France
Roxall Medizin

Completed

Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen

Allergic Rhinitis

Germany
Medibio Limited

Completed

Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes

Healthy | Depression, Unipolar | Depression, Bipolar

United States
Medibio Limited

Completed

Medibio DDA Confirmatory Performance Study

Major Depressive Episode

United States, Australia
Roxall Medizin

Unknown

A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts

Allergic Rhinitis | Allergic Conjunctivitis

Germany
Roxall Medizin

Unknown

Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites

Allergic Rhinitis

Spain
Roxall Medizin

Unknown

Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy

Allergic Rhinitis

Spain
MedSIR

Terminated

Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer (OPHELIA)

Advanced Breast Cancer

Spain
MedSIR

Terminated

A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent (NOBROLA)

Breast Cancer

Spain
MedSIR

Completed

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC (BioPER)

Metastatic Breast Cancer

Spain, Italy
MedSIR

Completed

Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes (KELLY)

Breast Cancer

Spain
MedSIR

Terminated

Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients

Breast Cancer

Spain
MedSIR

Completed

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus (POEM)

Carcinoma, Endometrioid | mTOR Protein

Spain
MedSIR

Completed

Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment (MERIBEL)

Breast Neoplasm | Metastasis

Spain
Medibio Limited

Completed

Analysis of Sleep Study Data to Assess Depressive Burden (SADB)

Mood Disorders | Sleep Disorder | Depressive; Behavioral Disorder

United States
Roxall Medizin

Unknown

Efficacy and Safety of Sublingual Immunotherapy (SLIT)

Allergic Rhinitis

Germany
Medistem Inc.

Unknown

Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia

Peripheral Vascular Diseases

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Photopill Medical Ltd

Completed

Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis (Photopill)

Ulcerative Colitis | Proctitis

Netherlands
MedSIR
Pfizer

Active, not recruiting

Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) (ZZ-First)

Metastatic Prostate Cancer

Spain
MedSIR
Bayer

Completed

Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

Prostate Cancer

Spain
MedSIR
AstraZeneca

Completed

Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M (AZENT)

Non-Small Cell Lung Cancer

Spain
MedSIR
Pfizer

Completed

PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) (PALMIRA)

Breast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Spain, Germany, France, United Kingdom, Italy, Slovenia
MedSIR
Pfizer

Completed

Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 - (DxCARTES)

Breast Cancer

Spain, Portugal
Zuyderland Medisch Centrum

Recruiting

Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients (TAILOR-AHF)

Heart Failure Acute

Netherlands

3

Subscribe